Patents by Inventor Mathieu Jospin

Mathieu Jospin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240358314
    Abstract: The continuous monitoring of electroencephalogram (EEG) and electrocardiogram (ECG) is crucial for detecting the degree of inflammation in a patient in a hospital setting, especially in the intensive care unit. In particular, the heart rate variability is known to correlate with the degree of inflammation. When the inflammation accelerates, this can lead to septic shock of the patient and subsequently multi-organ failure. Therefore, there is a need for a device that monitors the degree of sepsis of the patient. The present invention discloses a method and apparatus for monitoring the EEG and the ECG, and a method combining information from the EEG and the ECG which together with features extracted from the EEG and the ECG are the inputs to a prediction model such as an adaptive neuro fuzzy inference system the output of which is an index of sepsis.
    Type: Application
    Filed: July 4, 2024
    Publication date: October 31, 2024
    Inventor: Mathieu JOSPIN
  • Patent number: 11452480
    Abstract: The present invention disclosed a device and method for assessing in real time the hypnotic and analgesic effect in a subject during wakefulness, sedation and general anaesthesia via drug interactions and physiological signals. In a preferred embodiment of the present invention, the analgesic and hypnotic effect of drug(s) infused in a subject could be accurately assessed in real time through the device and method disclosed in the present invention, comprising steps of receiving data from electroencephalography (EEG) device, receiving data from brain impedance tomography device, obtaining pharmacodynamic and pharmacokinetic parameters of drug(s) infused in the subject, defining initial indices of consciousness and nociception as a function of said EEG and brain impedance tomography data, and generating output of final indices of consciousness and nociception in real time from processing input of EEG, brain tomography and drug interaction data using established mathematical manipulation.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: September 27, 2022
    Assignee: Quantium Medical SL
    Inventors: Erik Weber Jensen, Joan Fontantet, Mathieu Jospin
  • Publication number: 20180206784
    Abstract: The present invention disclosed a device and method for assessing in real time the hypnotic and analgesic effect in a subject during wakefulness, sedation and general anaesthesia via drug interactions and physiological signals. In a preferred embodiment of the present invention, the analgesic and hypnotic effect of drug(s) infused in a subject could be accurately assessed in real time through the device and method disclosed in the present invention, comprising steps of receiving data from electroencephalography (EEG) device, receiving data from brain impedance tomography device, obtaining pharmacodynamic and pharmacokinetic parameters of drug(s) infused in the subject, defining initial indices of consciousness and nociception as a function of said EEG and brain impedance tomography data, and generating output of final indices of consciousness and nociception in real time from processing input of EEG, brain tomography and drug interaction data using established mathematical manipulation.
    Type: Application
    Filed: April 7, 2016
    Publication date: July 26, 2018
    Inventors: Erik Weber Jensen, Joan Fontantet, Mathieu Jospin